Skip to content

Clinical trials

Completed Phase 1 Movement Disorders trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Movement Disorders Phase: Phase 1 Status: Completed Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20051
20071
20091
20113
20121
20151
20171
20181
20191
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Neurological Disorders and Stroke (NINDS)3
Siena Biotech S.p.A.2
University Children's Hospital, Zurich2
Biogen1
Cerevel Therapeutics, LLC1
Denali Therapeutics Inc.1
Heinrich-Heine University, Duesseldorf1
Neurocrine Biosciences1
Pfizer1
University of Saskatchewan1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Movement Disorders14
Parkinson Disease7
Nervous System Diseases6
Brain Diseases4
Central Nervous System Diseases4
Neurodegenerative Diseases4
Basal Ganglia Diseases3
Huntington Disease3
Chorea2
Cognition Disorders2

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.